Assistant Professor John Papastergiou and iPACT research team win prestigious international award

Assistant Professor John Papastergiou was part of a team that recently won a prestigious international award. The researchers won an Atrial Fibrillation Association Healthcare Pioneers Award for their pilot program “Pharmacist Contribution to Early Detection of Atrial Fibrillation – A Proof of Concept in Ten Countries”. The award was presented at the Heart Rhythm Congress 2018 held October 7-10 in Birmingham, United Kingdom.

Every year, the Atrial Fibrillation Association produces a Healthcare Pioneers report which identifies best practice in identification, diagnosis and treatment for care of patients with atrial fibrillation. The “Know Your Pulse” campaign organized by John and the team focused on the early detection of atrial fibrillation by community pharmacists. 

Atrial fibrillation is the most common cardiac arrhythmia globally, responsible for one third of strokes and often resulting in death or incapacity. This condition, frequently asymptomatic, is estimated to be up to 50% undiagnosed. Reducing this risk with appropriate detection and management strategies offers substantial economic and patient benefits. Both The European Society of Cardiology and The International Pharmacists for Anticoagulation Care Taskforce (iPACT) recommendscreening for atrial fibrillation by pulse taking or ECG rhythm strip in patients >65 years of age or other risk factors and (if needed) referred to a physician for diagnosis.

To learn more about the Know Your Pulse campaign, click here.